Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Codex Dna Inc (DNAY)

Codex Dna Inc (DNAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 38,379
  • Shares Outstanding, K 29,522
  • Annual Sales, $ 11,040 K
  • Annual Income, $ -38,960 K
  • 60-Month Beta 1.36
  • Price/Sales 1.82
  • Price/Cash Flow N/A
  • Price/Book 0.72
Trade DNAY with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.80
  • Most Recent Earnings $-0.42 on 11/08/22
  • Latest Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.45
  • Number of Estimates 2
  • High Estimate -0.45
  • Low Estimate -0.45
  • Prior Year -0.43
  • Growth Rate Est. (year over year) -4.65%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0801 +20.36%
on 12/07/22
1.4300 -9.09%
on 12/05/22
-0.0800 (-5.80%)
since 12/02/22
3-Month
1.0801 +20.36%
on 12/07/22
2.0400 -36.27%
on 10/24/22
-0.3100 (-19.25%)
since 10/03/22
52-Week
1.0801 +20.36%
on 12/07/22
11.0200 -88.20%
on 03/17/22
-8.4000 (-86.60%)
since 01/03/22

Most Recent Stories

More News
Codex DNA (DNAY) Reports Q3 Loss, Tops Revenue Estimates

Codex DNA (DNAY) delivered earnings and revenue surprises of 12.50% and 25.94%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

DNAY : 1.3000 (+8.33%)
AXDX : 0.9310 (-2.00%)
Codex DNA, Inc. (DNAY) Q2 2022 Earnings Call Transcript

DNAY earnings call for the period ending June 30, 2022.

DNAY : 1.3000 (+8.33%)
Codex DNA (DNAY) Reports Q2 Loss, Tops Revenue Estimates

Codex DNA (DNAY) delivered earnings and revenue surprises of 1.96% and 22.94%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

DNAY : 1.3000 (+8.33%)
AVGR : 3.70 (+0.27%)
Codex DNA Reports Second Quarter 2022 Financial Results

SAN DIEGO, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today reported...

DNAY : 1.3000 (+8.33%)
Penumbra (PEN) Surpasses Q2 Earnings and Revenue Estimates

Penumbra (PEN) delivered earnings and revenue surprises of 114.29% and 1.32%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

PEN : 206.15 (+0.22%)
DNAY : 1.3000 (+8.33%)
Silk Road Medical (SILK) Reports Q2 Loss, Tops Revenue Estimates

Silk Road Medical (SILK) delivered earnings and revenue surprises of 6.38% and 6.91%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

SILK : 17.57 (-0.57%)
DNAY : 1.3000 (+8.33%)
Codex DNA to Present at the 2022 Jefferies Healthcare Conference

SAN DIEGO, June 02, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced...

DNAY : 1.3000 (+8.33%)
Codex DNA Showcases Automated Synthetic Biology Solutions for Accelerating Discovery Workflows at the Antibody Engineering and Therapeutics Europe Conference

BioXpâ„¢ system and RapidAMPâ„¢ cell-free DNA kit rapidly accelerate antibody discovery pipelines by addressing critical bottlenecks associated with lead...

DNAY : 1.3000 (+8.33%)
Codex DNA, Inc. (DNAY) Q1 2022 Earnings Call Transcript

DNAY earnings call for the period ending March 31, 2022.

DNAY : 1.3000 (+8.33%)
Codex DNA to Report First Quarter 2022 Financial Results on Tuesday, May 10, 2022

SAN DIEGO, May 03, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced...

DNAY : 1.3000 (+8.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Codex DNA Inc. is a creator of the BioXp(TM) system, a fully automated benchtop instrument which enables numerous synthetic biology workflows. Codex DNA Inc. is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 1.4488
2nd Resistance Point 1.3791
1st Resistance Point 1.3395
Last Price 1.3000
1st Support Level 1.2302
2nd Support Level 1.1605
3rd Support Level 1.1209

See More

52-Week High 11.0200
Fibonacci 61.8% 7.2230
Fibonacci 50% 6.0501
Fibonacci 38.2% 4.8771
Last Price 1.3000
52-Week Low 1.0801

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar